Skip to main content
Clinical Trials/CTRI/2020/12/029925
CTRI/2020/12/029925
Completed
Phase 4

Single blind, randomized comparative study assessing clinical equivalence of two polyglactin 910 fast absorbing suture brands, Trusynth Fast�® and Vicryl Rapide�®, on maternal morbidity experienced by women following episiotomy repair

Healthium Medtech Pvt Ltd0 sites100 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: O80- Encounter for full-term uncomplicated delivery
Sponsor
Healthium Medtech Pvt Ltd
Enrollment
100
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
July 14, 2021
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Healthium Medtech Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\. Women aged 18\-40 years, with a singleton pregnancy
  • 2\. Primiparous or multiparous women who will require episiotomy during the course of vaginal delivery
  • 3\. Women with gestational age of \>34 weeks
  • 4\. Women with good systemic/ mental health as per opinion of investigator
  • 5\. Women who have given informed consent

Exclusion Criteria

  • 1\. Women with intrapartum fever and history of bleeding/coagulation disorders
  • 2\. Women having perineal tears, cervical tears, vaginal tears, extension of the episiotomies
  • 3\. Women who had a previous perineal surgery other than the primary repair after child birth
  • 4\. Women with known HIV or the hepatitis B infection
  • 5\. Women who has delivered a dead fetus
  • 6\. Women having any known allergy to the suture materials
  • 7\. Women already participating in another trial
  • 8\. Women unlikely to comply with study procedure or complete the scheduled follow up visit, in the opinion of investigator
  • 9\. Other indication\-based exclusion, in the opinion of investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials